Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


New CFO at WuXi PharmaTech

This article was originally published in Scrip

Executive Summary

The China-based contract research organisation WuXi PharmaTech has named Edward Hu chief financial officer. He has served as chief operating officer since January 2008 and was previously acting CFO from February 2009 to May 2010. Hao Zhou, the company's current CFO, is leaving the company. Charles River Laboratories recently conceded to shareholder pressure and terminated its acquisition of WuXi, paying the CRO a $30 million break-up fee (, 30 July 2010).





Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts